QNTM and QNTM.CN Related Headlines

Go Back

Sep 17, 2026 08:00AM Rodman & Renshaw Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$8 Price Target
Sep 11, 2026 08:30AM Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials

QNTM and QNTM.CN Related Press Releases

Go Back

Sep 17, 2026 08:00AM Rodman & Renshaw Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$8 Price Target
Sep 11, 2026 08:30AM Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials

QNTM and QNTM.CN Related SEC Filings

Go Back